According to MRFR study, the implantable port market size in 2024 is predicted to be USD 3,290.28 million. The Implantable Port Market Industry is predicted to develop at a CAGR of 6.21% from 2025 to 2035.
The Implantable Port Market is being pushed by rising chronic disease rates, which are driving in need for long-term intravenous access options. As healthcare providers strive to improve patient comfort and treatment effectiveness, implanted ports are gaining popularity. The expansion of outpatient and home healthcare settings drives up demand, as these institutions require dependable and effective medication administration methods. Furthermore, developments in medical technology result in safer, more durable implants, which drives market expansion. The market offers opportunities for the development of materials that increase biocompatibility and reduce infection concerns, paving the way for more novel implantable port designs. With a rising emphasis on patient-centered care, there is opportunity to include digital health technologies, such as remote monitoring systems, to improve patient management. Expanding knowledge among healthcare professionals about the benefits of implantable ports can help boost market adoption, particularly in underdeveloped countries where such technologies are still being adopted. Recent trends show a shift towards minimally invasive procedures, making implantable ports increasingly desirable to both patients and healthcare practitioners. Manufacturers and physicians are increasingly collaborating to improve the design and functionality of these devices.
Market Segment insights
The global implanted port market is divided into three material types: silicone, polyurethane, and titanium.
The global implantable port market is divided into four application categories: chemotherapy, antibiotic therapy, complete parenteral nutrition, and blood transfusion.
The global implantable port market is divided into two segments based on the mode of insertion: surgical and percutaneous. The surgical insertion segment accounted for the greatest market share in 2024 and is expected to grow the fastest throughout the forecast period.
Regional insights
The global implantable port market is divided into five regions: North America, Europe, Asia-Pacific, South America, and the Middle East and Africa. North America held the biggest market share in 2024 and is expected to reach USD 2,416.61 million by 2035. However, Asia-Pacific is expected to develop at the fastest CAGR of 8.32% over the projection period.
The North American implantable port market was worth USD 1,382.75 million in 2024, and it is expected to increase at a CAGR of 5.20% over the forecast period. North America is further divided into the United States and Canada.
The Europe implantable port market was worth USD 972.35 million in 2024 and is expected to increase at a CAGR of 6.41% over the forecast period. Europe is further divided into Germany, France, the United Kingdom, Italy, Spain, Russia, and the rest of Europe.
Major Players
Easton Medical, Baxter International, Zyga Technology, Terumo, Apex Medical Technologies, Medtronic, Boston Scientific, Cook Medical, AngioDynamics, Kirwan Surgical Products, Smiths Medical, Nitinol Devices Corporation, C R Bard, Stryker, and Halyard Health are among the key players in the implantable port market.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook